This site is intended for healthcare professionals
  • Home
  • /
  • Journals
  • /
  • Rheumatoid arthritis
  • /
  • No increased incidence of inflammatory bowel disea...

No increased incidence of inflammatory bowel disease among secukinumab-treated patients with moderate to severe psoriasis, psoriatic arthritis, or ankylosing spondylitis: data from 14 phase 2 and phase 3 clinical studies.

Read time: 1 mins
Published:28th Sep 2016
Author: Schreiber S, Sands BE, Deoshar A, Huang J, Ghandi K, Karyekar C, et al.
Availability: Pay for access, or by subscription
Ref.:Arthritis Rheumatol. 2016; 68 (suppl 10).
Register for free access to this exclusive healthcare learning resource

Why sign up with Medthority?

Develop your knowledge with our disease and condition focused Learning Zones

Access content from credible sources, including expert-led commentary, videos, podcasts, and webinars as well as clinical trials, treatment information and guidelines 

Personalised dashboard providing updates and recommendations for content within your areas of interest